Corporate Travel Management Ltd (CTD)
Australian Securities Exchange · Australia · prices in AUD · close of 21 Oct 2026
Key indicators
| Last close | AUD 3.290 |
|---|---|
| 52-week range | 1.970 – 16.070 |
| Return, 1 month / 3 months | +20.1% / −79.5% |
| Return, 1 year / 3 years | −79.5% / −79.7% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 196.9% |
| Worst drawdown (1 year) | -87.6% |
| Average daily value traded | 4.21M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Corporate Travel Management is a business travel management company based in Brisbane, Australia. It provides corporate clients with services for arranging and managing work-related travel, including booking flights and accommodation, managing travel expenses, and supporting traveller safety and tracking. Its customers are organisations that need help organising and controlling the travel of their employees, and it serves clients across several regions through local offices.
On this site Corporate Travel Management Ltd appears as a stock on the Australian Securities Exchange (Australia), code CTD, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Corporate Travel Management Ltd (CTD) trades on the Australian Securities Exchange in Australia. It last closed at AUD 3.290 on 21 October 2026.
Its price-based Market X-Ray is 12 out of 100 (a weak price profile), ranking 1,764 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 79.5% and over the last three months it fell 79.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 3 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -76.0% | ||
| From 52-week high | -79.5% | ||
| Momentum | 1 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -79.5% | ||
| 6-month return | -79.5% | ||
| 12-month return, skipping the last month | -83.0% | ||
| Stability (higher is calmer) | 3 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 196.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -87.6% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.21M AUD | ||
| Zero-volume days | 41.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +25.6% |
|---|---|
| 1 month | +20.1% |
| 3 months | −79.5% |
| 6 months | −79.5% |
| 1 year | −79.5% |
| 3 years | −79.7% |
| 5 years | −85.7% |
Signals
| 50-day / 200-day average | 6.523 / 13.683 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.270 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Feb 2025 | AUD 0.1000 |
| 29 Aug 2024 | AUD 0.1200 |
| 29 Feb 2024 | AUD 0.1700 |
| 5 Sep 2023 | AUD 0.2200 |
| 14 Mar 2023 | AUD 0.0600 |
| 5 Sep 2022 | AUD 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.